DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 2Amneal Pharmaceuticals
03 2ENDO OPERATIONS
04 2Sucampo Pharmaceuticals
05 2Teva Pharmaceutical Industries
06 2Zydus Pharmaceuticals
01 12CAPSULE;ORAL
01 2DISCN
02 10RX
01 2AMITIZA
02 10LUBIPROSTONE
01 12USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : LUBIPROSTONE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 8MCG
Packaging :
Approval Date : 2022-02-08
Application Number : 206994
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : LUBIPROSTONE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 24MCG
Packaging :
Approval Date : 2022-02-08
Application Number : 206994
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUBIPROSTONE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 8MCG
Packaging :
Approval Date : 2021-11-30
Application Number : 209450
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUBIPROSTONE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 24MCG
Packaging :
Approval Date : 2021-11-30
Application Number : 209450
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMITIZA
Dosage Form : CAPSULE;ORAL
Dosage Strength : 24MCG
Packaging :
Approval Date : 2006-01-31
Application Number : 21908
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMITIZA
Dosage Form : CAPSULE;ORAL
Dosage Strength : 8MCG
Packaging :
Approval Date : 2008-04-29
Application Number : 21908
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUBIPROSTONE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 8MCG
Packaging :
Approval Date : 2022-01-18
Application Number : 209920
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUBIPROSTONE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 24MCG
Packaging :
Approval Date : 2022-01-18
Application Number : 209920
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUBIPROSTONE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 8MCG
Packaging :
Approval Date : 2023-03-23
Application Number : 214131
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUBIPROSTONE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 24MCG
Packaging :
Approval Date : 2023-03-23
Application Number : 214131
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUBIPROSTONE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 8MCG
Packaging :
Approval Date : 2022-06-27
Application Number : 201442
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUBIPROSTONE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 24MCG
Packaging :
Approval Date : 2022-06-27
Application Number : 201442
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?